Congress has an unprecedented opportunity to bring better benefits (including prescription drugs), higher quality, and more cost-effective care to Medicare beneficiaries. But that depends on whether leaders of the Senate and the House of Representatives can find politically acceptable solutions that provide a new vision for an old program. Is the Federal Employee Health Benefits Program a good model for Medicare? How should a consumer-driven drug benefit plan be incorporated in the bill? How can technology be integrated more effectively to improve quality, safety, and efficiency, while resulting in a reduction of medical errors and costs?

In addition to the panel discussion, there will be a display of innovative technology in the registration area.